Wednesday, March 29, 2023 11:40:26 AM
https://www.pharmather.com/news/pharmather-holdings-provides-update-for-ketarxtm-racemic-ketamine-development-programs-and-expected-milestones-for-2023#:~:text=KETARX%E2%84%A2%20Type%20C%20meeting%20granted%20by%20FDA%20for,treatment%20of%20levodopa-induced%20dyskinesia%20in%20Parkinson%E2%80%99s%20disease%20%28%E2%80%9CLID-PD%E2%80%9D%29.
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM